Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00006384
Recruitment Status : Completed
First Posted : December 24, 2003
Last Update Posted : October 20, 2011
National Cancer Institute (NCI)
Information provided by (Responsible Party):
City of Hope Medical Center